Projects per year
Abstract
With the surge of next-generation technologies the scientific community awareness to gut ecosystem importance on human health has been increasing. In the context of inflammatory and cardiometabolic disorders, which have major clinical/economic impact [1], the gut resident Akkermansia muciniphila emerges as a next-generation probiotic, due to its potential in their prevention/treatment [2][3]. However, the high sensitivity to acidic conditions and its aerotolerant metabolism hampers functional foods/nutraceuticals development [4]. To overcome such challenges, a combination of two cryoprotective agents was evaluated on the protection of microencapsulated A. muciniphila when exposed to detrimental conditions.
| Original language | English |
|---|---|
| Pages | 1-1 |
| Number of pages | 1 |
| Publication status | Published - Apr 2022 |
| Event | 3.º BioIberoAmerica 2022 - Altice Forum Braga, Braga, Portugal Duration: 7 Apr 2022 → 9 Apr 2022 Conference number: 3 https://www.bioiberoamerica2022.com/en/home |
Conference
| Conference | 3.º BioIberoAmerica 2022 |
|---|---|
| Abbreviated title | BioIberoAmerica 2022 |
| Country/Territory | Portugal |
| City | Braga |
| Period | 7/04/22 → 9/04/22 |
| Internet address |
Fingerprint
Dive into the research topics of 'Evaluation of microencapsulation impact on akkermansia muciniphila’ culturability during freeze-drying, storage under different temperatures and atmospheric conditions, and in vitro gastrointestinal passage'. Together they form a unique fingerprint.Projects
- 1 Finished
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver